Skip to main content
. 2020 Mar 4;11(1):311–317. doi: 10.1080/21655979.2020.1736755

Table 1.

Association of miR-125b level expression with clinicopathological characteristics in patients with ovarian cancer.

Groups No. Relative miR-125b level (fold) p-Value
Age     0.274
 ≤50 70 0.836 ± 0.147  
 <50 82 0.897 ± 0.153  
Histological subtype     0.073
 Serous 103 0.812 ± 0.136  
 Others 49 0.856 ± 0.145  
FIGO stage     <0.001
 I/II 30 0.924 ± 0.158  
 III/IV 122 0.682 ± 0.132  
Tumor grade     0.186
 Well + moderate 70 0.846 ± 0.162  
 Poor 82 0.836 ± 0.247  
CA125     0.242
 ≦35 23 0.826 ± 0.116  
 >35 129 0.848 ± 0.132  
Lymph node status     0.032
 No 103 0.875 ± 0.158  
 Yes 49 0.804 ± 0.162  
Distant metastasis     0.146
 No 127 0.868 ± 0.125  
 Yes 25 0.829 ± 0.144